Back
Axsome Therapeutics Stock Price Chart

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
AXSM
Axsome Therapeutics
Last Price:
$107.94
Seasonality Move:
19.74%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.
Axsome Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 118.38 | Sell |
20-day SMA: | 121.53 | Sell |
50-day SMA: | 118.82 | Sell |
200-day SMA: | 95.87 | Buy |
8-day EMA: | 116.81 | Sell |
20-day EMA: | 120.13 | Sell |
50-day EMA: | 116.68 | Sell |
200-day EMA: | 99.37 | Buy |
Axsome Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.51 | Sell |
Relative Strength Index (14 RSI): | 34.09 | Sell |
Chaikin Money Flow: | -196956 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (117.79 - 127.47) | Sell |
Bollinger Bands (100): | (89.81 - 121.33) | Buy |
Axsome Therapeutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 109.75 while AXSM 8-day simple moving average is 118.38, which is a Sell signal.
-
The stock price of AXSM is 109.75 while Axsome Therapeutics 20-day SMA is 121.53, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 118.82 while AXSM share price is 109.75, making it a Sell technically.
-
AXSM stock price is 109.75 and Axsome Therapeutics 200-day simple moving average is 95.87, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
37
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $109.75. The Score for AXSM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.4B
Price in USD:
109.75
Share Volume:
902.2K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
37
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 109.75 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 109.75 while AXSM 8-day exponential moving average is 116.81, which is a Sell signal.
-
The stock price of AXSM is 109.75 while Axsome Therapeutics 20-day EMA is 120.13, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 116.68 while AXSM share price is 109.75, making it a Sell technically.
-
AXSM stock price is 109.75 and Axsome Therapeutics 200-day simple moving average is 99.37, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -1.51, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 34.09, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (117.79 - 127.47), which suggest Axsome Therapeutics is a Buy
-
The Bollinger Bands (100) for Axsome Therapeutics is (89.81 - 121.33), which suggest Axsome Therapeutics is a Buy
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.